Ramanadham Smita R, Mapula Steven, Costa Christopher, Narasimhan Kailash, Coleman Jayne E, Rohrich Rod J
Dallas, Texas From the Departments of Plastic Surgery and General Surgery, University of Texas Southwestern Medical Center.
Plast Reconstr Surg. 2015 Apr;135(4):1037-1043. doi: 10.1097/PRS.0000000000001131.
Hematoma continues to be the most common complication after rhytidectomy. Perioperative hypertension is a known risk factor, and meticulous control of this has been shown to significantly reduce the incidence of postoperative hematoma development, thus improving outcomes and decreasing patient morbidity. Despite this, there are few well-described hypertension management regimens in the literature today.
A retrospective chart review of 1089 patients undergoing rhytidectomy performed by a single surgeon was conducted. A predetermined antihypertensive protocol was used in all patients that included the routine use of transdermal clonidine. A target systolic blood pressure of 140 mmHg or less was the goal of therapy, and close hemodynamic monitoring was used throughout the entire perioperative phase. The incidence of postoperative hematoma was then assessed.
The overall incidence of postoperative hematoma was 0.9 percent (10 patients). Of these patients, five were female (0.05 percent) and five were male (5.2 percent). Preoperatively, 170 patients were noted to be hypertensive, with a systolic blood pressure greater than 140 mmHg. Postoperatively, 355 patients were found to be hypertensive (p < 0.001). Of the patients who developed a postoperative hematoma, eight patients (80 percent) had documented hypertension (systolic blood pressure >140 mmHg) in the postanesthesia care unit (p = 0.045). Male sex was found to be a significant risk factor for the development of hematoma (p < 0.001).
Meticulous perioperative blood pressure control significantly reduces the rate of postoperative hematoma formation. The use of a specific protocol developed by our senior author and primary anesthesia provider contributed to our very low hematoma rates.
血肿仍然是除皱术后最常见的并发症。围手术期高血压是一个已知的危险因素,对其进行细致控制已被证明可显著降低术后血肿形成的发生率,从而改善手术效果并降低患者发病率。尽管如此,目前文献中很少有详细描述的高血压管理方案。
对由一位外科医生实施除皱术的1089例患者进行回顾性病历审查。所有患者均采用预定的降压方案,其中包括常规使用透皮可乐定。治疗目标是收缩压降至140 mmHg或更低,并在整个围手术期进行密切的血流动力学监测。然后评估术后血肿的发生率。
术后血肿的总体发生率为0.9%(10例患者)。其中,女性5例(0.05%),男性5例(5.2%)。术前,170例患者被诊断为高血压,收缩压大于140 mmHg。术后,355例患者被发现患有高血压(p < 0.001)。在发生术后血肿的患者中,8例(80%)在麻醉后护理单元记录有高血压(收缩压>140 mmHg)(p = 0.045)。男性被发现是血肿形成的一个重要危险因素(p < 0.001)。
围手术期细致的血压控制可显著降低术后血肿形成率。我们资深作者和主要麻醉提供者制定的特定方案的使用促成了我们极低的血肿发生率。